Video
Oral Semaglutide: Cardiovascular Outcomes, Safety, and Tolerability
The safety profile of oral semaglutide across the PIONEER trials was shown to be consistent with other glucagon-like peptide-1 receptor agonists (GLP-1RAs).
Click PLAY to watch the video abstract.
Click here to watch the full supplement infographic.
Click here to read full article to this video abstract.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
